Skip to content

Clinical trials

Phase 1 Severe Acute Respiratory Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Severe Acute Respiratory Syndrome Phase: Phase 1 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20208
20216
20222
20234
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Withdrawn5
Unknown status4
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lahore General Hospital3
National Institute of Allergy and Infectious Diseases (NIAID)2
Pfizer2
VBI Vaccines Inc.2
Vaccine Company, Inc.2
Alvea Holdings, LLC1
Bharat Biotech International Limited1
Biomed Industries, Inc.1
CureVac1
Henry Ford Health System1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Severe Acute Respiratory Syndrome23
COVID-1918
Coronavirus Infections10
Cognitive Dysfunction1
Nerve Degeneration1
Neuroinflammatory Diseases1
Pneumonia1

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.